Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, South Korea.
World J Gastroenterol. 2010 Jun 14;16(22):2806-11. doi: 10.3748/wjg.v16.i22.2806.
To evaluate the safety and outcomes of endoscopic piecemeal mucosal resection (EPMR) for large sessile colorectal polyps.
The patients enrolled in this study were 47 patients with 50 large sessile polyps (diameter, 2 cm or greater) who underwent EPMR using a submucosal saline injection technique between December 2002 and October 2005. All medical records, including characteristics of the patients and polyps, complications, and recurrences, were retrospectively reviewed. The first follow-up endoscopic examination was performed at 3-6 mo after initial endoscopic resection, and the second at 12 mo post-EPMR. Subsequent surveillance colonoscopic examinations were individualized, taking risk factors into account.
The patients were 23 men and 24 women, with a mean age of 60 years. Mean polyp size was 30.1 mm. Of 50 polyps identified, 34 (68%) were benign and 16 (32%) were malignant. There were 6 (12%) cases with EPMR-related bleeding: 5 intra-procedural and 1 early post-procedural bleeding. All bleeding episodes were managed by endoscopic clipping or argon beam coagulation. There were no perforations. Recurrence was identified in 5 cases (12.2%): 4 local recurrences detected at 3 mo post-EPMR and 1 local recurrence detected at 14 mo post-EPMR. The recurrence rate after EPMR was 3.1% for benign polyps and 33.3% for malignant polyps (P < 0.05). Median follow-up time was 37 mo.
EPMR is safe, but should be applied carefully in malignant polyps. Close follow-up endoscopic examinations are necessary for early detection of recurrence.
评估内镜分片黏膜切除术(EPMR)治疗大型无蒂结直肠息肉的安全性和疗效。
本研究纳入了 2002 年 12 月至 2005 年 10 月期间采用黏膜下生理盐水注射技术行 EPMR 的 47 例 50 枚直径≥2cm 的大型无蒂息肉患者。回顾性分析所有患者的病历资料,包括患者和息肉的特征、并发症和复发情况。初次内镜切除术后 3-6 个月行首次随访内镜检查,EPMR 后 12 个月行第二次随访内镜检查。后续的结肠镜检查根据风险因素个体化进行。
患者中男 23 例,女 24 例,平均年龄 60 岁。息肉平均直径 30.1mm。50 枚息肉中,34 枚(68%)为良性,16 枚(32%)为恶性。EPMR 相关出血 6 例(12%):术中 5 例,术后早期 1 例。所有出血事件均经内镜夹闭或氩气刀凝固成功止血。无穿孔发生。5 例(12.2%)患者复发:EPMR 后 3 个月时发现 4 例局部复发,EPMR 后 14 个月时发现 1 例局部复发。EPMR 后良性息肉的复发率为 3.1%,恶性息肉的复发率为 33.3%(P<0.05)。中位随访时间为 37 个月。
EPMR 安全有效,但在恶性息肉中应谨慎应用。密切随访内镜检查对于早期发现复发至关重要。